What is the maximum period for a drug therapy modification protocol between a physician and a pharmacist?

The maximum period for a drug therapy modification protocol between a physician and a pharmacist is indeed two years. This time frame is significant because it establishes a structured and regularly revisited relationship between the physician and pharmacist regarding patient care. Having a defined limit helps ensure that the protocol is frequently evaluated for relevance and effectiveness, promoting ongoing communication and collaboration between healthcare providers.

This two-year period allows for necessary updates or adjustments to reflect changes in clinical guidelines, patient needs, or emerging evidence. It safeguards patient safety and enhances the quality of care, as pharmacists can make informed adjustments to therapy under the guidance of a clearly specified and timely reviewed protocol. By requiring reassessment every two years, the legislation encourages active participation by both the physician and pharmacist in the ongoing management of the patient's drug therapy.